Overall survival of patients (diabetic patients and nondiabetic patients, diabetic patients affected with glycemia control, groups according to the number of abnormal items).
Introduction Recent studies demonstrated that circulating fibroblast growth factor (FGF)-23 was associated with risk of end stage renal disease (ESRD) and mortality. This study aims to examine whether
The aim of this study was to test the association between glycemic variability and mortality. It is a retrospective cohort with convenience sample composed of 30 medical records of patients of both se
Although gut bacterial dysbiosis is recognized as a regulator of beta-cell autoimmunity, no data is available on fungal dysbiosis in the children at the risk of type 1 diabetes (T1D). We hypothesized
